Lv3
206 积分 2022-07-12 加入
Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody–Drug Conjugates
16天前
已完结
Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors
16天前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
26天前
已完结
Suppressive Immune Response of Poly(sarcosine) Conjugated Proteins: PSARylation
30天前
已完结
Antibody‐Drug Conjugates for the Treatment of Cancer
1个月前
已完结
NQO1-responsive Trimethyl lock benzoquinone: A cleavable linker strategy for antibody-drug conjugates
2个月前
已完结
Phase II Study of Intravenous DX‐8951f in Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane, and Topotecan
2个月前
已完结
DX‐8951f: Summary of Phase I Clinical Trials
2个月前
已完结
Chemo-biocatalytic regioselective one-pot synthesis of different deprotected monosaccharides
2个月前
已完结
Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
2个月前
已完结
皖公网安备34019202002308
